Plus Therapeutics reported $-4.4M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Baxter International USD 474M 165M Jun/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Haemonetics USD 111.41M 15.25M Sep/2026
Northwest Biotherapeutics USD -13.41M 232K Sep/2023
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Sanofi EUR 5.79B 2.1B Sep/2026
Starpharma Holdings AUD -4.85M 1.73M Dec/2024
Sun Pharmaceuticals INR 47.44B 3.26B Sep/2026
Teva Pharmaceutical Industries USD 1.5B 1.02B Sep/2026